Brendan P. Eckelman net worth and biography

Brendan Eckelman Biography and Net Worth

Insider of Inhibrx Biosciences

Dr. Eckelman co-founded Inhibrx in April 2010 and currently serves as our Chief Scientific Officer and Executive Vice President of Corporate Strategy. From August 2015 to November 2018, he served as our Chief Operating Officer and Vice President of Biotherapeutics. From 2010 until August 2015, Dr. Eckelman served as our Vice President of Scientific Operations. He has served as a member of our board of directors since April 2018.

Dr. Eckelman is the head of our research team, overseeing several key functional areas spanning discovery to therapeutic development. In addition, he has critical responsibilities in corporate strategy and operations. Prior to co-founding Inhibrx, Dr. Eckelman was a Research Investigator in the biotherapeutics group at the Genomics Institute of the Novartis Research Foundation. He conducted his graduate research at the Sanford-Burnham-Prebys Medical Discovery Institute and received a Ph.D. in Molecular Pathology from the University of California, San Diego (UCSD), School of Medicine. Dr. Eckelman received his B.S. in Molecular Biology and his M.S. in Biology from UCSD.

What is Brendan P. Eckelman's net worth?: The estimated net worth of Brendan P. Eckelman is at least $151.70 million as of May 28th, 2024. Dr. Eckelman owns 1,735,553 shares of Inhibrx Biosciences stock worth more than $151,704,688 as of December 5th. This net worth estimate does not reflect any other assets that Dr. Eckelman may own. Additionally, Dr. Eckelman receives a salary of $769,250.00 as Insider at Inhibrx Biosciences. Learn More about Brendan P. Eckelman's net worth.
How old is Brendan P. Eckelman?: Dr. Eckelman is currently 45 years old. There are 3 older executives and no younger executives at Inhibrx Biosciences. The oldest executive at Inhibrx Biosciences is Mr. Mark Paul Lappe, Founder, Chairman, President & CEO, who is 57 years old. Learn More on Brendan P. Eckelman's age.
What is Brendan P. Eckelman's salary?: As the Insider of Inhibrx Biosciences, Inc., Dr. Eckelman earns $769,250.00 per year. The highest earning executive at Inhibrx Biosciences is Mr. Mark Paul Lappe, Founder, Chairman, President & CEO, who commands a salary of $1,100,000.00 per year. Learn More on Brendan P. Eckelman's salary.
How do I contact Brendan P. Eckelman?: The corporate mailing address for Dr. Eckelman and other Inhibrx Biosciences executives is 11025 N. TORREY PINES ROAD SUITE 200, LA JOLLA CA, 92037. Inhibrx Biosciences can also be reached via phone at 858-795-4220 and via email at [email protected]. Learn More on Brendan P. Eckelman's contact information.
Has Brendan P. Eckelman been buying or selling shares of Inhibrx Biosciences?: Brendan P. Eckelman has not been actively trading shares of Inhibrx Biosciences during the past quarter. Most recently, Brendan P. Eckelman sold 300,000 shares of the business's stock in a transaction on Tuesday, May 28th. The shares were sold at an average price of $34.30, for a transaction totalling $10,290,000.00. Following the completion of the sale, the insider now directly owns 1,735,553 shares of the company's stock, valued at $59,529,467.90. Learn More on Brendan P. Eckelman's trading history.
Who are Inhibrx Biosciences' active insiders?: Inhibrx Biosciences' insider roster includes Brendan Eckelman (Insider), Jeffrey Jensen (EVP & Chief Clinical Devel. Officer), Jon Kayyem (Director), Mark Lappe (Founder), Mark Lappe (CEO), and Kristiina Vuori (Director). Learn More on Inhibrx Biosciences' active insiders.
Are insiders buying or selling shares of Inhibrx Biosciences?: During the last twelve months, insiders at the sold shares 1 times. They sold a total of 350,000 shares worth more than $11,287,500.00. The most recent insider tranaction occured on October, 7th when Major Shareholder Global Investors Lp Viking sold 350,000 shares worth more than $11,287,500.00. Insiders at Inhibrx Biosciences own 17.1% of the company. Learn More about insider trades at Inhibrx Biosciences.
Information on this page was last updated on 10/7/2025.

Brendan P. Eckelman Insider Trading History at Inhibrx Biosciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/28/2024	Sell	300,000	$34.30	$10,290,000.00	1,735,553
2/1/2023	Sell	28,750	$24.73	$710,987.50	2,086,803
1/3/2023	Sell	32,895	$23.77	$781,914.15	2,122,658
12/6/2022	Sell	40,000	$27.22	$1,088,800.00	2,155,553
11/1/2022	Sell	40,000	$33.51	$1,340,400.00	2,195,553
10/4/2022	Sell	40,000	$27.82	$1,112,800.00	2,235,553
8/2/2022	Sell	24,500	$17.70	$433,650.00	2,491,053
7/7/2022	Sell	40,000	$17.17	$686,800.00	2,515,553
4/5/2022	Sell	400	$25.04	$10,016.00
3/24/2021	Sell	17,000	$19.02	$323,340.00
2/16/2021	Sell	17,000	$25.90	$440,300.00	234,709

Brendan P. Eckelman Buying and Selling Activity at Inhibrx Biosciences

Inhibrx Biosciences Company Overview

Inhibrx, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidate includes INBRX-101, an alpha-1 antitrypsin (AAT)-Fc fusion protein therapeutic candidate, which is in Phase 1 clinical trials for use in the treatment of patients with AAT deficiency. It also develops INBRX-109, a tetravalent therapeutic candidate targeting death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, colorectal cancer, ewing sarcoma, and pancreatic adenocarcinoma; and INBRX-106, a hexavalent agonist of OX40 for a range of oncology indications. The company has license and collaboration agreements with 2seventy bio, Inc. and Bristol-Myers Squibb Company. Inhibrx, Inc. was incorporated in 2009 and is headquartered in La Jolla, California.

Today's Range

Now: $87.41

$81.49

$89.43

50 Day Range

MA: $61.01

$28.36

$87.41

2 Week Range

Now: $87.41

$10.81

$89.43

Volume

275,711 shs

Average Volume

261,355 shs

Market Capitalization

$1.27 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.18

Brendan Eckelman Biography and Net Worth

What is Brendan P. Eckelman's net worth?

How old is Brendan P. Eckelman?

What is Brendan P. Eckelman's salary?

How do I contact Brendan P. Eckelman?

Has Brendan P. Eckelman been buying or selling shares of Inhibrx Biosciences?

Who are Inhibrx Biosciences' active insiders?

Are insiders buying or selling shares of Inhibrx Biosciences?